In addition, higher levels of NLRP3 and caspase-1 were observed in patients with rheumatoid arthritis than in patients with degenerative arthritis, and it was found that the administration of selective NLRP3 inhibitors reduced redness and cartilage degradation [57]. Here, CASP1 is linked to rheumatoid arthritis.